Mergers & Acquisitions Mergers & Acquisitions

Illumina lodges appeal against EU regulator's Grail deal interim measures

Illumina lodged an appeal at the EU courts on Wednesday contesting the European Commission’s imposition of interim measures related to its Grail acquisition, MLex has learned.

The US gene-sequencing company is challenging the EU merger regulator's measures of Oct. 29, which it imposed following Illumina's decision to forge ahead with its acquisition of the

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News